63020-049 : Velcade 3.5 mg/1 Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution


NDC: 63020-049
Labeler: Millennium Pharmaceuticals, Inc.
Product Type: Human Prescription Drug
Drug Name:  Velcade
Dosage Form: Intravenous; Subcutaneous Injection, Powder, Lyophilized, for Solution
Application #: NDA021602
Rev. Date: 


NDC Package Codes:

  • 63020-049-01: 1 VIAL IN 1 CARTON (63020‑049‑01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION IN 1 VIAL (63020‑049‑04)

Active Ingredients:

  • Bortezomib

Dosage Strength:

  • 3.5 mg

Pharmaceutical Classes:

  • Proteasome Inhibitor [EPC]
  • Proteasome Inhibitors [MoA]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63020-049 QR Code

< Prev: 63020-040Next: 63020-078 >

Related Discussions:

gabantin-Bortezomib induced peripheral neuropathy(BINP)
I am a multiple myeloma patient, undergone 3 cycles of chemotherapy with bortezomib,and undergone autologus bonemarrow t... 1 reply
is velcade dangerous to a caregiver
hi i was wondering my 76 year old father n law lives with me and is receiving velcade is it harmfull to anyone in the ho... 2 replies
velcade
...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.